UC, UC Health to launch Phase 3 clinical trial for COVID-19 vaccine
Vaccine uses a genetic code to produce proteins that may generate protective antibodies
Researchers at the University of Cincinnati and UC Health will host a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19, the respiratory illness caused by the novel coronavirus SARS-CoV-2.
UC is one of approximately 90 sites across the United States selected for the study, which will administer the vaccine candidate mRNA-1273 to volunteer participants and monitor its efficacy in eliciting an immune response that provides protection from COVID-19. The National Institute of Allergy and Infectious Diseases, (NIAID), part of the National Institutes of Health, is funding the study.
Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases, medical director of the COVID-19 vaccine trial. Photo/Colleen Kelley/UC Creative + Brand
“UC was chosen because we have a proven track record of high-quality research and are the number one site in the NIAID-funded, AIDS Clinical Trials Group in the U.S. We are proud to bring leading-edge research to Cincinnati so that we can help our community battle the COVID-19 pandemic and be part of the solution,” said Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases at the UC College of Medicine and a UC Health physician.
Fichtenbaum is co-investigator of the study and will serve as medical director.
Read the full story here.
Featured photo of COVID-19 vials by Colleen Kelley/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
UC Speech & Hearing Clinic serves patients while acting as training site
September 30, 2026
The University of Cincinnati's Speech & Hearing Clinic provides graduate students in audiology and speech-language pathology with hands-on experience while delivering care to patients across the region. Located on the university's medical campus, the clinic serves patients of all ages and was recently featured on Spectrum News 1 Ohio.
Now strollers are getting an electric upgrade
September 30, 2026
Following the trend of e-bikes and e-scooters, several baby gear brands have announced strollers with battery-boosted assist and other autonomous features. But are these pricey new strollers (most cost more than $2,000) just a flashy status symbol, or can they deliver real benefits? A University of Cincinnati disability expert recently offered her perspective to Forbes.
Rewarding blood & platelet donors this October at Hoxworth
September 30, 2026
As the need for lifesaving blood and platelets continues, Hoxworth Blood Center at the University of Cincinnati is giving donors extra reasons to give this October with an exclusive Buddy-themed wearable blanket and the launch of its new Platelet Power Points rewards program.